BIRTHPLACE IN AUSTRALIA: A PROSPECTIVE COHORT STUDY
Funder
National Health and Medical Research Council
Funding Amount
$834,782.00
Summary
There is considerable debate about the safety of maternity services in Australia. This has been increased by the National Maternity Services Review and the National Maternity Plan with particular concerns about homebirth and birth centres. This study aims to examine the safety of place of birth for healthy women. This national study will include women across the country. It is the first time such a study has been undertaken in Australia and will provide much needed evidence as to the safety of p ....There is considerable debate about the safety of maternity services in Australia. This has been increased by the National Maternity Services Review and the National Maternity Plan with particular concerns about homebirth and birth centres. This study aims to examine the safety of place of birth for healthy women. This national study will include women across the country. It is the first time such a study has been undertaken in Australia and will provide much needed evidence as to the safety of place of birth.Read moreRead less
The Gudaga Study is a unique study of Aboriginal children in an urban environment on the eastern seaboard of Australia. Children were recruited at birth and have been followed up at 6-monthly intervals to age 5 years. This research aims to describe the health, early learning and service context of these urban Aboriginal children from 5 to 9 years. Detailed longitudinal data on Aboriginal children's early life experiences have not previously been collected in an urban setting.
Quantifying The Burden Of Atrial Fibrillation: Impact Of Existing And New Treatments And The Potential For Prevention
Funder
National Health and Medical Research Council
Funding Amount
$398,395.00
Summary
Atrial fibrillation (AF) causes considerable morbidity and burden to the Australian economy. We will quantify the prevalent burden and costs of hospitalised AF, ascertain the risk of major events associated with AF and the impact of existing treatments, and determine the population-attributable risk for AF due to emerging risk factors. Our data will inform clinicians and health policy makers regarding the most effective allocation of expensive health care resources to minimise the burden of AF.
Understanding Health Service System Needs For People With Intellectual Disability
Funder
National Health and Medical Research Council
Funding Amount
$1,216,389.00
Summary
The health of people with intellectual disability (ID) is one of the poorest of any group in Australia. People with ID experience higher rates of ill health, poor access to responsive health services and premature death. Our research will develop the first comprehensive profile of health, health service and medicines use and costs for people with ID, and will examine the impact of the National Disability Insurance Scheme (NDIS) on these metrics.
Pharmaceutical Opioids For Chronic Non-cancer Pain: Evaluating Health Outcomes And Economic Impact Over Five Years
Funder
National Health and Medical Research Council
Funding Amount
$775,922.00
Summary
Chronic non-cancer pain (CNCP) is a major contributor to disability. Increased opioid prescribing for CNCP has produced concern about dependence and overdose in the absence on data on its long-term effectiveness. Novel statistical methods will test causal relationships over 5 years between treatment, outcomes, and costs on 1,514 CNCP patients prescribed opioids. We will answer critical questions on 5-year outcomes, and whether, and for whom, opioids and other clinical interventions reduce costs.
Improving Efficiency Of Surveillance Colonoscopy For Colorectal Cancer Prevention
Funder
National Health and Medical Research Council
Funding Amount
$643,123.00
Summary
Greater awareness of bowel cancer screening has led to increased demand and waiting times for colonoscopy. National guidelines recognise the need for research to identify the best use of colonoscopy to ensure health funds are directed where they are needed. This study aims to identify how often colonoscopy is required for the best patient outcomes. Data about cancer and death will be linked to hospital and laboratory data to identify which patients need more or less surveillance colonoscopies.
Measuring Low-value Health Care For Targeted Policy Action
Funder
National Health and Medical Research Council
Funding Amount
$806,176.00
Summary
It is claimed that up to 30% of (U.S.) health care represents waste, including the use of unsafe and ineffective health care practices. While many agree the problem exists, little empirical work has been completed to test this 30% figure, particularly in Australia. We will quantify the extent of, and variability in, waste across Australian health datasets (stand-alone and linked). This project will be the first of its kind in Australia and the largest and most comprehensive internationally.
Optimising Care For Patients Diagnosed With Pancreatic Cancer: A Prospective Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$1,399,839.00
Summary
There is evidence from previous research in Queensland and NSW that elements of care provided to patients with pancreatic cancer are sub-optimal. We aim to improve compliance with evidence-based guidelines in Victoria and NSW by collecting high quality data, providing reports to hospitals benchmarking their performance against peers and working with health services to reduce variation. Making sure care known to improve practice is being delivered is as important as developing new targeted thera
Long Term Evaluation Of Uptake, Impact And Outcomes Of The 75+ Health Assessment
Funder
National Health and Medical Research Council
Funding Amount
$204,897.00
Summary
This project will evaluate uptake, outcomes and costs of the 75+ Health Assessment using data from the Australian Longitudinal Study on Women's Health (ALSWH) linked to Medicare data. The ALSWH provides prospective data through regular surveys, and these longitudinal data will allow comprehensive evaluation from the introduction of the assessments through to their longer term outcomes in very old age.
Is Highly-sensitive Troponin Testing Advancing Clinical Practice, Improving Outcomes And Cost-effective In The Investigation And Management Of Chest Pain In The Emergency Department?
Funder
National Health and Medical Research Council
Funding Amount
$1,193,966.00
Summary
Expensive next generation blood tests offer the promise of more efficient detection of heart muscle damage in people with chest pain presenting to the Emergency Department. We aim to evaluate the treatment, management, cost and outcome at 1 year before and after these new blood tests were introduced in a national multi-hospital study.